載入...
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Adrenocortical carcinoma (ACC) is a rare, highly aggressive cancer, often insensitive to conventional chemotherapeutics agents. Early diagnosis, followed by radical surgical resection plus/minus adjuvant mitotane therapy, is nowadays the only valuable option. Unfortunately, one out of four patients...
Na minha lista:
| 發表在: | J Oncol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463568/ https://ncbi.nlm.nih.gov/pubmed/31057613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6072863 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|